Virtual Event
Benzinga Virtual Events -- Reclassifying Cannabis: What the HHS Recommendation Means for the Cannabis Market
THURS. SEPTEMBER 14 | 11 AM EST
The U.S. Department of Health & Human Services (HHS) made headlines in recent weeks, recommending marijuana be reclassified from Schedule I to Schedule III under federal law. So, what will this mean for the cannabis market in 2024? Join us as we look at the science, policy and business issues at the center of this momentous development.
SPEAKERS
-
Adam Stettner
CEO
FundCanna -
Eric Berlin
Partner, Co-Head Cannabis Group
Dentons -
Hunter Land, PhD
VP, Research & Development
Biopharmaceutical Research Company -
David Traylor
Sr. Managing Director
Golden Eagle Partners -
Pablo Zuanic
Managing Partner
Zuanic & Associates -
David Mangone
Director of Policy
The Liaison Group
